Mar 08, 2023 / 03:30PM GMT
Joshua Thomas Jennings - TD Cowen, Research Division - MD & Senior Research Analyst
Again, my name is Josh Jennings. I'm leading the medical devices team here at TD Cowen. And we're excited to continue down the medical devices track at the 43rd Annual TD Cowen Health Care Conference. We're thrilled to have the Insulet team here today to join us for a fireside chat. Let me make a quick introduction. We have President and CEO, Jim Hollingshead; and Executive Vice President and Chief Financial Officer, Wayde McMillan.
Gentlemen, thanks so much for coming over at -- I guess, south from your headquarters, is that right, and coming down to Boston and having this discussion. We're going to let you kick off with some introductory remarks. And we'll dive into a little bit of Q&A, if that's okay.
James R. Hollingshead - Insulet Corporation - President, CEO & Director
Great. That's perfect. Thanks, Josh. Thanks for having us. Good morning, everybody. Great to see you all. Just a couple of quick comments. I'm guessing most of you in the room know us
Insulet Corp at Cowen Health Care Conference Transcript
Jan 23, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers